Article info

Download PDFPDF

Short report
Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression

Authors

  1. Correspondence to Dr Dinesh Khanna; khannad{at}umich.edu
View Full Text

Citation

Khanna D, Maher TM, Volkmann ER, et al
Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression

Publication history

  • Received November 11, 2022
  • Accepted February 2, 2023
  • First published February 16, 2023.
Online issue publication 
February 16, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.